August 2023 - Page 2 of 3 - BioMedWire (BMW)

WednesdayAug 23, 2023 9:00 am

Renovaro BioSciences Inc. (NASDAQ: RENB), Immunotherapy Biotech Company, Announces Intention to Unite With AI Tech Developer GEDi Cube, Seen as Major Multiplier Effect in the Fight Against Cancer

Combination of advanced AI machine learning technology and proven immunotherapy technology seen as “future of medicine” Demonstrated success that both companies have shown with their innovative developments is expected to expand synergistically Potential applications against variety of cancers The announcement of a binding and exclusive letter of intent to merge, between two of the most innovative companies in their respective fields, is seen as representing a potentially transformative step in the fight against cancer. Considering Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy, that has already demonstrated significant results with its technology against pancreatic…

TuesdayAug 22, 2023 4:04 pm

How Allergy Sufferers Can Benefit from Immunotherapy

The Centers for Disease Control and Prevention (CDC) estimates that close to one in three adults and more than one in every four children in America have a food allergy, seasonal allergy or eczema. Close to 6% of children and adults in the country have a food allergy and 25.7% of U.S. adults have a seasonal allergy, 7.3% have eczema, and 6.2% report having a food allergy. Common allergy treatment approaches include medications to minimize immune system reaction and alleviate symptoms, epinephrine in emergencies and immunotherapy for severe cases. Immunotherapy is the preferred treatment option for people with allergies that…

MondayAug 21, 2023 1:33 pm

Insider Intelligence Data Projects Health, Personal Care, Beauty eCommerce to Grow Fastest

Recent analysis by market research firm Insider Intelligence has revealed that the fastest-growing sales category in e-commerce is foods and drinks. The market researcher predicts that the food and drink e-commerce segment will expand by 20% in 2023 to reach $99.70 billion in sales and account for 8.8% of total e-commerce sales in the United States. According to Insider Intelligence, the food and drinks segment will comprise up to 10% of America’s total e-commerce sales by the year 2026. Insider Intelligence forecasting analyst Whitney Birdsall explains that inflation is partly responsible for the growth of the food and drinks sales…

FridayAug 18, 2023 1:01 pm

Analyzing Link Between Hormonal Contraceptives, Autoimmunity

Autoimmune diseases occur when the immune system mistakes healthy tissues for harmful bacteria, viruses, or infections and starts to attack the body. Referred to as autoimmunity, this phenomenon causes significant damage to healthy tissues and results in more than 100 autoimmune conditions. Data has consistently shown that women are four times more likely to develop autoimmune diseases compared to men. While some researchers have posited that the X chromosome may increase the risk of autoimmunity in women because it is more likely to cause a higher number of mutations, we still don’t know why autoimmune diseases affect women at much…

FridayAug 18, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Advances NanoAb Therapy as IL-17 Drug Candidate for Psoriasis Treatment

Similar business model but different antibody therapies for psoriasis treatment, BiondVax uses NanoAbs while Apogee Therapeutics, Inc. uses conventional mAbs BiondVax NanoAbs provide superior benefits not seen in mAb therapies, including new routes of administration, higher affinity, better binding, and a higher level of stability at room temperature Apogee recently went public at $500 million pre-money, raising $300 million in an upsized deal, and has a $1 billion market cap – should be an eye-opener to BiondVax investors who recognize benefits of NanoAbs over mAb development The global psoriasis treatment market was valued at $26.13 billion in 2022 and is…

ThursdayAug 17, 2023 1:44 pm

Researchers Develop Novel Way to Detect Pediatric Brain-Cancer Mutations

Uppsala University researchers have created a novel method for detecting brain-cancer mutations in children, granting scientists an unprecedented glimpse into the inner workings of pediatric brain tumors. The novel technique allowed the researchers to determine that the mutations they saw changed how tumor cells interact with cancer drugs, potentially opening the door for the development of better means of diagnosing pediatric brain cancer and building personalized treatment plans. Medulloblastoma, a type of brain tumor that originates in the cerebellum, is the most common type of brain cancer in children. It has a 70% survival rate after five years if treatment…

WednesdayAug 16, 2023 3:26 pm

Amazon Clinic Becomes Available Nationwide as Company Expands Footprint

Retail e-commerce giant Amazon recently announced that Americans in all 50 states as well as Washington, D.C., can now access its virtual clinic. Amazon launched Amazon Clinic in November 2022 following its February purchase of healthcare provider One Medical with the aim of providing customers with direct access to third-party healthcare providers via its mobile app and website. Customers can use either option to book online appointments and seek treatment for a myriad of common medical conditions, including hair loss, urinary tract infections, pink eye, asthma, seasonal allergies, high blood pressure and migraines. According to a recent statement from Amazon,…

TuesdayAug 15, 2023 2:43 pm

Stem Cell Transplants Followed by Immunotherapy Show Efficacy Against Pediatric Nerve Tumors

A new cancer treatment protocol that involves transplanting stem cells into cancer patients and then taking them through immunotherapy has proven to be quite effective at treating pediatric nerve tumors. Researchers from the Eberhard Karls University of Tübingen and St. Anna Children’s Cancer Research Institute found that harvesting stem cells from the parents of children with pediatric nerve tumors gives the patient a new immune system that’s much better at responding to immunotherapy. Nerve tumors are mutated growths that develop in or on peripheral nerves. They typically affect the tissues that support nerve cells, are typically noncancerous and can be…

MondayAug 14, 2023 2:45 pm

How Healthcare eCommerce Impacts Traditional Providers of Healthcare

Several years after the coronavirus pandemic forced most industries to either shut down or adopt remote working, the healthcare industry is still adapting to e-commerce. E-commerce had been a dominant form of trade by the time the pandemic struck, and the healthcare industry slowly incorporated e-commerce features such as online consultations, online medication orders and home deliveries to prevent the spread of the disease. The purchase of healthcare provider One Medical by e-commerce giant Amazon in early 2023 significantly increased the company’s presence in healthcare and cemented the ties between medicine and e-commerce. Generally, the introduction of e-commerce to medicine…

MondayAug 14, 2023 11:15 am

BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) Alpaca-Derived Nanobodies for Potential Treatment of Diseases Underserved by Current Therapeutics

Innovative nanobody therapeutics could deliver substantial competitive advantages in both cost and efficacy when compared to traditional monoclonal antibody therapies The biologics market was valued at $366.5 billion in 2021 and is expected to grow to a value of $719.94 billion by 2030 The monoclonal antibodies market was valued at $210.06 billion in 2022, and it is expected to reach $494.53 billion by 2030 The nanobody market was valued $237.1 million in 2021 and is expected reach a value of $1.07 billion by 2028 BiondVax is uniquely positioned to rapidly advance from R&D towards commercialization BiondVax Pharmaceuticals (NASDAQ: BVXV), a…